Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitorsOA
Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitors
Di Shao;Tianjian Yu;Yi Xiao;Zhiming Shao
Department of Breast Surgery,Fudan University Shanghai Cancer Center,Shanghai 200032,China||Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,ChinaDepartment of Breast Surgery,Fudan University Shanghai Cancer Center,Shanghai 200032,China||Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,ChinaDepartment of Breast Surgery,Fudan University Shanghai Cancer Center,Shanghai 200032,China||Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,ChinaDepartment of Breast Surgery,Fudan University Shanghai Cancer Center,Shanghai 200032,China||Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China
Cancer-immunity cycletumor immunityimmune checkpoint inhibitorbreast cancerPSAT1
Cancer-immunity cycletumor immunityimmune checkpoint inhibitorbreast cancerPSAT1
《癌症生物学与医学（英文版）》 2026 (6)
925-945,21
This work was supported by grants from the National Key Research and Development Project of China(Grant No.2020YFA0112304)and the National Natural Science Foundation of China(Grant Nos.82441028,82202883 and 82573645).
评论